Lexicon Pharmaceuticals | Stammkapital





Stammkapital Veränderung Datum
Abbott USD 1.74B 23.39B 2025-09
Acadia Pharmaceuticals USD 168.71M 104K 2025-09
Agios Pharmaceuticals USD 58.28M 241K 2025-09
Akebia Therapeutics USD 2K 0 2025-03
Alnylam Pharmaceuticals USD 131.79M 130.49M 2025-09
AstraZeneca USD 1.55B 206K 2025-12
BioMarin Pharmaceutical USD 192.1M 97K 2025-09
Coherus Biosciences USD 12K 0 2025-03
Eli Lilly USD 946.83M 354.23M 2025-06
Esperion Therapeutics USD 112K 11K 2023-09
Halozyme Therapeutics USD 117.52M 98K 2025-09
Illumina USD 152.8M 900K 2025-12
Insmed USD 212.58M 210.76M 2025-09
Ironwood Pharmaceuticals USD 160K 0 2024-12
J&J USD 2.41B 584K 2025-09
MacroGenics USD 63.26M 62.63M 2025-09
MannKind USD 307.03M 303.99M 2025-09
Merck USD 2.49B 15.79M 2025-09
Moderna USD 391M 2M 2025-09
Novartis USD 1.94B 23.4M 2025-06
PTC Therapeutics USD 79.93M 554K 2025-09
Puma Biotechnology USD 5K 0 2024-06
Sarepta Therapeutics USD 104.77M 7.06M 2025-09
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
United Therapeutics USD 42.9M 42.1M 2025-09
Vanda Pharmaceuticals USD 58K 0 2024-12


Lexicon Pharmaceuticals Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.